Interested candidates include Canonsburg, Pa.-based Mylan, Ahmedabad, India-based Torrent Pharmaceuticals and Petah Tikva, Israel-based Teva Pharmaceuticals.
Bayer’s dermatology products include Desonate, used to treat eczema, and Finacea, a treatment for rosacea. The business could sell for as much as $1.1 billion, according to the report.
More articles on supply chain:
Amgen, Arrowhead Pharma to collaborate on gene-silencing drugs
Uber to develop technology to connect truckers and carriers
CMS warned Mylan about EpiPen rebate issues multiple times
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
